FindTrial
Sign In

Experimental Device,No Intervention Drug

3 trials

Sponsors

Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Siriraj Skin Laser Center, ratchadapisek fund

Conditions

COVID&#45Patients with melasma that did not response to at least 2% hydroquinone cream-containing regimen after 3 months melasma laser 577nmmyopia progrssion Defocus incorporated multiple segments (DIMS) spectacles, myopia, myopia progression, myopia control, atropine, Pediatrics, Randomized controlled trial

Phase 4

Efficacy of HOSPSL 577nm laser in Melasma Treatment
Active, not recruitingTCTR20210618003
Siriraj Skin Laser CenterPatients with melasma that did not response to at least 2% hydroquinone cream-containing regimen after 3 months melasma laser 577nm
Start: 2015-05-28Target: 20Updated: 2026-08-03
Additive effect of defocus incorporated multiple segments (DIMS) spectacles to low dose atropine for myopic control in children
RecruitingTCTR20251209014
ratchadapisek fundmyopia progrssion Defocus incorporated multiple segments (DIMS) spectacles, myopia, myopia progression, myopia control, atropine, Pediatrics, Randomized controlled trial
Start: 2024-09-24Target: 30Updated: 2026-08-03

Unknown Phase

Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19
Active, not recruitingTCTR20200409006
Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial HospitalCOVID&#45
Start: 2020-05-01Target: 206Updated: 2026-08-03